CinCor Pharma, Inc., (CINC): Price and Financial Metrics
CINC Price/Volume Stats
| Current price | $29.06 | 52-week high | $43.15 |
| Prev. close | $29.20 | 52-week low | $10.53 |
| Day low | $29.02 | Volume | 6,349,700 |
| Day high | $29.35 | Avg. volume | 818,447 |
| 50-day MA | $22.81 | Dividend yield | N/A |
| 200-day MA | $24.66 | Market Cap | 1.27B |
CINC Stock Price Chart Interactive Chart >
CinCor Pharma, Inc., (CINC) Company Bio
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardiovascular diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension and primary aldosteronism, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.
CINC Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...